Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7131)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2015 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ge WS, Fan JG. Integrin antagonists are effective and safe for Crohn’s disease: A meta-analysis. World J Gastroenterol 2015; 21(15): 4744-4749 [PMID: 25914486 DOI: 10.3748/wjg.v21.i15.4744] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i15/4744.htm |
| Number | Citing Articles |
| 1 |
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen, A Barney Hawthorne. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019; 68(Suppl 3): s1 doi: 10.1136/gutjnl-2019-318484
|
| 2 |
Seana ML Nelson, Tran M Nguyen, John WD McDonald, John K MacDonald. Natalizumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2018; 2018(8) doi: 10.1002/14651858.CD006097.pub3
|
| 3 |
Peijian He, Abedul Haque, Songbai Lin, Fabio Cominelli, C. Chris Yun. Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na+/H+ exchanger 3 in SAMP1/Fc mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 315(5): G762 doi: 10.1152/ajpgi.00215.2018
|
| 4 |
Sophia Ponciano de Souza, Paulo Gabriel Marques Leite, Ana Júlia Oliveira Silva, Camila Belfort Piantino Faria. O USO DO VEDOLIZUMBABE NO TRATAMENTO DA DOENÇA DE CRONH: UMA REVISÃO INTEGRATIVA. REVISTA FOCO 2024; 17(7): e5563 doi: 10.54751/revistafoco.v17n7-017
|
| 5 |
Doreen E. Szollosi, Kirsten Hokeness, Mohammed K. Manzoor. Pharmacology of Immunotherapeutic Drugs. 2020; : 207 doi: 10.1007/978-3-030-19922-7_7
|
| 6 |
Laith Alrubaiy, Louise Christine Pitsillides, Thomas O’Connor, Matilda Woodhill, Harry Higgins, Thaer Khaleel Swaid, Doa’a Alkhader, Zaher Koutoubi. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE). Gastrointestinal Disorders 2024; 6(3): 644 doi: 10.3390/gidisord6030043
|
| 7 |
Subrata Ghosh, Brian Bressler, Jill Petkau, Roopal B. Thakkar, Song Wang, Martha Skup, Jingdong Chao, Remo Panaccione, Stefan Schreiber. Healthcare Providers Underestimate Patients’ Glucocorticoid Use in Crohn’s Disease. Digestive Diseases and Sciences 2019; 64(5): 1142 doi: 10.1007/s10620-018-5419-3
|